Dr. Paul Janssen honoured for over 40 years pioneering new therapies for severe mental illnesses

July 09, 2000

10th July 2000, Brussels -- Yesterday Dr Paul Janssen received the CINP*- Pfizer Pioneers in Psychopharmacology Award for his outstanding work in revolutionising the lives of millions of patients with psychiatric illnesses around the world.

Presenting the award, Professor Helmut Beckmann, President of the CINP explained "We honour and celebrate Dr Paul Janssen's historic contribution to the development of therapies for patients with mental illnesses. He, and others like him, allowed patients around the world to recover hope and attain a quality of live that they would otherwise be denied."

Dr Paul was born in 1926, the son of a Flemish general practitioner, and grew up in an era without many effective treatments for even the most common of diseases. In 1953 he established Janssen Pharmaceutica which today has developed more than 75 compounds worldwide, four of which are recognised by the World Health Organisation as essential drugs.

His development of HALDOL® (haloperidol) in 1958 quickly revolutionised the treatment of psychosis and allowed patients to be returned from psychiatric hospitals into the community. In 1993, RISPERDAL® (risperidone), a new generation antipsychotic, was introduced, and is now the first choice antipsychotic around the world and recently became the most prescribed atypical antipsychotic in the USA.

"Psychiatry today is indebted to Dr Paul Janssen's vital contributions. He, in collaboration with many others, has changed the boundaries of medical knowledge and empowered the global medical community with effective medicines that have changed lives for the better around the globe" continued Professor Beckmann.

Dr Paul Janssen said "This is a great honour and I am proud to accept this award. It is particularly special to be recognised in my own country in the presence of Her Majesty the Queen Fabiola of Belgium. I would like to also thank my colleagues from around the world, many of whom are here today, for their efforts which have led us collectively to change the face of modern psychiatry."
Janssen Pharmaceutica is located in Beerse, Belgium. Risperdal is marketed globally by Janssen-Cilag, and in partnership with NV Organon in the European Union (except for Italy, Spain and Finland, where it is marketed by Janssen-Cilag only), Norway, Switzerland, Brazil and Argentina.

Notes for editors

For further information, please contact:

In Brussels
Anna Korving: mobile 44-410-420-523
Roseann Ward: mobile 44-7770-794235

In London
John Gisborne: 44-20-7465-8753
Ross Williams: 44-20-7465-7043

Ketchum UK

Related Mental Illnesses Articles from Brightsurf:

World Mental Health Day -- CACTUS releases report of largest researcher mental health survey
On the occasion of 'World Mental Health Day' 2020, CACTUS, a global scientific communications company, has released a global survey on mental health, wellbeing and fulfilment in academia.

Mental illness, mental health care use among police officers
A survey study of Texas police officers examines how common mental illness and mental health care use are in a large urban department.

New method of detecting illnesses including coronavirus and cystic fibrosis
A new and quicker method of diagnosing diseases in patients has been created by researchers.

Emergency visits for thunderstorm-related respiratory illnesses
Researchers used atmospheric and lightning data for all counties in the continental United States from 1999 through 2012 to see if increases in emergency department visits for respiratory illnesses among older adults happen in the days surrounding thunderstorms because vulnerable groups and those with common chronic respiratory diseases may be susceptible to the atmospheric changes caused by these storms.

Unexpected mental illnesses found in a spectrum of a rare genetic disorder
UC Davis MIND Institute researchers found an unexpected spectrum of mental illnesses in patients with a rare gene mutation.

New study suggests ways to alleviate social withdrawal symptoms in mental illnesses
University of California, Davis, researchers studied the role of oxytocin, a neurotransmitter produced in the hypothalamus, which is known to play an important role in social behavior across species.

Skills training opens 'DOORS' to digital mental health for patients with serious mental illness
Digital technologies, especially smartphone apps, have great promise for increasing access to care for patients with serious mental illness such as schizophrenia.

Portable lab you plug into your phone can diagnose illnesses like coronavirus
Engineers with the University of Cincinnati have created a tiny portable lab that plugs into your phone, connecting it automatically to your doctor through a custom app UC developed.

New score measuring multiple chronic illnesses performs better than current method
A new score that measures multiple long-term health conditions performs better than the current Charlson Comorbidity Index and may help in health care planning and delivery, according to new research in CMAJ (Canadian Medical Association Journal).

Novel composite antimicrobial film could take a bite out of foodborne illnesses
A novel composite film -- created by the bonding of an antimicrobial layer to conventional, clear polyethylene plastic typically used to vacuum-package foods such as meat and fish -- could help to decrease foodborne illness outbreaks, according to researchers in Penn State's College of Agricultural Sciences.

Read More: Mental Illnesses News and Mental Illnesses Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.